Study of NGM831 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

Clinical Trials, Metastatic Castration Resistant Prostate Cancer (MCRPC), Metastatic Castration Sensitive Prostate Cancer (MCSPC), Non-Metastatic Castration Resistant Prostate Cancer (nMCRPC)

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT05215574
Phase: Phase 1
Trial Summary: Study of NGM831 as Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): NGM Biopharmaceuticals, Inc|Merck Sharp & Dohme LLC
Acronym:

Pin It on Pinterest